164 related articles for article (PubMed ID: 7520677)
21. Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients.
Mayordomo JI; Rivera F; Cortes-Funes H
Support Care Cancer; 1995 Jan; 3(1):84-5. PubMed ID: 7535169
[No Abstract] [Full Text] [Related]
22. [The treatment of infections in patients with neutropenia (a review of the literature with the inclusion of the authors' own data)].
Ptushkin VV; Bagirova NS; Volkova MA
Ter Arkh; 1998; 70(7):83-7. PubMed ID: 9742648
[No Abstract] [Full Text] [Related]
23. Agents under investigation for the treatment and prevention of neutropenia.
Huston A; Lyman GH
Expert Opin Investig Drugs; 2007 Nov; 16(11):1831-40. PubMed ID: 17970641
[TBL] [Abstract][Full Text] [Related]
24. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
25. A tale of two growth factors.
Fruehauf JP; Kong KM; Wong SF; Chan HO
Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
[No Abstract] [Full Text] [Related]
26. Granulocyte-macrophage colony-stimulating factor in neutropenia.
Hogan KR; Peters MD
DICP; 1991 Jan; 25(1):32-5. PubMed ID: 2008785
[No Abstract] [Full Text] [Related]
27. [Appropriate use of granulocyte-colony stimulating factor].
Ohashi K; Kiura K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():336-40. PubMed ID: 25831778
[No Abstract] [Full Text] [Related]
28. [Myelosuppression due to antineoplastic agents].
Shigeoka Y; Shimizu E
Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
[No Abstract] [Full Text] [Related]
29. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children.
Riikonen P
Stem Cells; 1995 May; 13(3):201-5. PubMed ID: 7613488
[TBL] [Abstract][Full Text] [Related]
30. Successful short-term treatment with granulocyte-macrophage colony-stimulating factor of neutropenia due to cytotoxic chemotherapy of chronic lymphocytic leukemia.
Rave K; Brittinger G
Ann Hematol; 1991 Dec; 63(6):333. PubMed ID: 1756194
[No Abstract] [Full Text] [Related]
31. [Granulocyte colony stimulating factor in the ambulatory treatment of neutropenia following chemotherapy].
Ruiz LP; Aguila JD; Cedeño AM
Rev Panam Salud Publica; 2009 Sep; 26(3):281-2. PubMed ID: 20058839
[No Abstract] [Full Text] [Related]
32. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
33. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
34. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
35. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
Goa KL; Bryson HM
Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
[TBL] [Abstract][Full Text] [Related]
36. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
Carrato A; Guillén-Ponce C; Grande-Pulido E
Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
[TBL] [Abstract][Full Text] [Related]
37. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
38. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
39. Colony-stimulating factors for neutropenia in glycogen storage disease Ib.
Schroten H; Wendel U; Burdach S; Roesler J; Breidenbach T; Schweitzer S; Zeidler C; Welte K
Lancet; 1991 Mar; 337(8743):736-7. PubMed ID: 1706047
[No Abstract] [Full Text] [Related]
40. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
Croockewit AJ; Koopmans PP; de Pauw BE
Clin Pharmacol Ther; 1996 Jan; 59(1):1-6. PubMed ID: 8549028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
